Skip to search formSkip to main contentSkip to account menu

phosphoaspirin

Known as: 3-((diethoxyphosphoryloxy)methyl)phenyl 2-acetoxybenzoate 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

AspirinOrganophosphates

Narrower (1)

MDC 43
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.
Aspirin is chemopreventive against colon and probably other cancers, but this effect is relatively weak and its chronic… 
2008
2008
The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin).
We have synthesized a series of novel phenylester compounds and present our assessment of such a derivative of aspirin, 3… 
Highly Cited
2008
Highly Cited
2008
The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.
Anticancer agents act, at least in part, by inducing reactive oxygen and nitrogen species (RONS). We examined the redox effect on… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)